We are live on ! Find out more
SCA

STALEY CAPITAL ADVISERS Portfolio holdings

AUM $2.36B
1-Year Est. Return 23.72%
This Fund
S&P 500
This Quarter Est. Return
-2.55%
1 Year Est. Return
+23.72%
3 Year Est. Return
+72.54%
5 Year Est. Return
+79.76%
10 Year Est. Return
+284.42%
AUM
$1.82B
AUM Growth
-$41.9M
Cap. Flow
+$14.2M
Cap. Flow %
0.78%
Top 10 Hldgs %
44.7%
Holding
184
New
2
Increased
74
Reduced
57
Closed
9

Sector Composition

Rank Sector Weight
1 Technology 24.69%
2 Financials 9.84%
3 Healthcare 9.74%
4 Consumer Discretionary 7.77%
5 Industrials 7.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DHR icon
151
Danaher
DHR
$138B
$273K 0.02%
1,242
-44
-3% -$9.81K
NRK icon
152
Nuveen New York AMT-Free Quality Municipal Income Fund
NRK
$905M
$250K 0.01%
26,500
COST icon
153
Costco
COST
$417B
$249K 0.01%
441
+62
+16% +$34.2K
COIN icon
154
Coinbase
COIN
$39.9B
$248K 0.01%
3,300
POOL icon
155
Pool Corp
POOL
$7.35B
$239K 0.01%
672
DVY icon
156
iShares Select Dividend ETF
DVY
$23.7B
$220K 0.01%
2,041
RIVN icon
157
Rivian
RIVN
$22.4B
$206K 0.01%
+8,500
New +$198K
PPG icon
158
PPG Industries
PPG
$26.3B
$205K 0.01%
1,577
+9
+0.6% +$1.26K
NUV icon
159
Nuveen Municipal Value Fund
NUV
$1.91B
$202K 0.01%
24,500
-1,100
-4% -$9.36K
FOR icon
160
Forestar Group
FOR
$1.49B
$201K 0.01%
1,870
+20
+1% +$551
PFXF icon
161
VanEck Preferred Securities ex Financials ETF
PFXF
$2.47B
$190K 0.01%
11,300
PARA
162
DELISTED
Paramount Global Class B
PARA
$159K 0.01%
12,360
PMO
163
Franklin Municipal Opportunities Trust
PMO
$280M
$115K 0.01%
12,500
PHAT icon
164
Phathom Pharmaceuticals
PHAT
$681M
$104K 0.01%
10,000
EVV
165
Eaton Vance Limited Duration Income Fund
EVV
$1.07B
$98K 0.01%
10,837
-282
-3% -$2.62K
NAZ icon
166
Nuveen Arizona Quality Municipal Income Fund
NAZ
$157M
$96.3K 0.01%
10,000
YARW
167
Yarrow Bioscience, Inc. Common Stock
YARW
$26.1M
$94.8K 0.01%
469
PL icon
168
Planet Labs
PL
$8.02B
$78K ﹤0.01%
30,000
MTNB icon
169
Matinas BioPharma
MTNB
$1.84M
$52K ﹤0.01%
8,000
-4,000
-33% -$49.1K
GNPX icon
170
Genprex
GNPX
$2.17M
$19.7K ﹤0.01%
1
BIV icon
171
Vanguard Intermediate-Term Bond ETF
BIV
$28.9B
-7,334
Closed -$552K
BSV icon
172
Vanguard Short-Term Bond ETF
BSV
$44.6B
-23,579
Closed -$1.78M
DGRO icon
173
iShares Core Dividend Growth ETF
DGRO
$43.4B
-5,605
Closed -$289K
QUAL icon
174
iShares MSCI USA Quality Factor ETF
QUAL
$48B
-2,233
Closed -$301K
SCHE icon
175
Schwab Emerging Markets Equity ETF
SCHE
$12.9B
-10,069
Closed -$248K

Similar funds

STALEY CAPITAL ADVISERS's Q3 2023 Portfolio in Review

As of Q3 2023, STALEY CAPITAL ADVISERS held 184 positions worth $1.82B, down 2.3% from $1.86B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

STALEY CAPITAL ADVISERS's Q3 2023 filing shows 2 new, 74 increased, 57 reduced and 9 closed positions. Its largest new stake was Thermo Fisher Scientific: 559 shares worth $283K. The largest sale was PIMCO Enhanced Short Maturity Active Exchange-Traded Fund, an estimated $13.7M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Financials and Healthcare.

  • STALEY CAPITAL ADVISERS's largest Q3 2023 buy was Thermo Fisher Scientific: 559 shares worth $283K.
  • STALEY CAPITAL ADVISERS added most to International Flavors & Fragrances in Q3 2023, an estimated $23.9M increase.
  • STALEY CAPITAL ADVISERS's biggest Q3 2023 reduction was PIMCO Enhanced Short Maturity Active Exchange-Traded Fund, cutting an estimated $13.7M.
  • STALEY CAPITAL ADVISERS fully exited Vanguard Short-Term Bond ETF in Q3 2023, selling an estimated $1.78M.
  • STALEY CAPITAL ADVISERS's ten largest holdings make up 45% of its $1.82B portfolio in Q3 2023.
  • STALEY CAPITAL ADVISERS opened 2 new positions and closed 9 in Q3 2023.
  • STALEY CAPITAL ADVISERS's portfolio value fell 2.3% quarter-over-quarter to $1.82B.

Based on STALEY CAPITAL ADVISERS's 13F filing for Q3 2023, filed 14 Nov 2023.